Agilent Technologies Intrinsic Value Calculation – Agilent Technologies Beats Expectations with Non-GAAP EPS of $1.27 and Revenue of $1.72B

🌥️Trending News

Agilent Technologies ($NYSE:A), Inc. is a multinational technology company that provides a broad range of products, processes, and services for the life sciences, diagnostics, and applied chemical markets. The company recently reported Non-GAAP EPS of $1.27, which exceeded expectations by $0.01, while revenue of $1.72B beat predictions by $50M. This news has been well-received by investors and has pushed the stock price to new highs. Agilent Technologies provides laboratory-based solutions that cover a wide range of industries, such as pharmaceuticals, biotechnology, chemical analysis, and environmental testing. Their solutions are used by government agencies, universities, and private businesses around the world. Agilent also produces a full line of instruments, such as mass spectrometers and chromatographs, to meet the needs of their customers in the chemical analysis space.

In addition to their core offerings, Agilent Technologies has recently expanded into the software side of the industry. The company is now providing cloud-based software solutions that allow customers to access data quickly and make informed decisions in real-time. This shift towards software-based solutions has been increasingly popular amongst customers and has allowed Agilent Technologies to maintain their competitive advantage in the market. The company’s ability to beat expectations on both the top and bottom lines highlights their commitment to delivering value for shareholders. With their diverse portfolio of products and services, Agilent Technologies is well-positioned to capitalize on any opportunities that arise in the near future.

Earnings

This is a 4.9% increase in total revenue and 24.4% increase in net income compared to the previous year. The results have exceeded expectations, with investors delighted by the company’s strong performance. AGILENT TECHNOLOGIES has successfully implemented strategies that have resulted in increased profitability and steady growth, positioning the company for long-term success.

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Agilent Technologies. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Agilent Technologies. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Agilent Technologies. More…

Key Ratios Snapshot

Some of the financial key ratios for Agilent Technologies are shown below. More…

Share Price

Agilent Technologies recently reported its financial results for the quarter and beat analyst expectations. The report pushed AGILENT TECHNOLOGIES stock to open at $129.0 Tuesday morning, but fell 0.3% to $128.6 by the close. Despite the slight dip, the company still achieved solid results and exceeded market expectations. The earnings report helps to solidify confidence in AGILENT TECHNOLOGIES and its stock, which has seen success in recent weeks. Live Quote…

Analysis – Agilent Technologies Intrinsic Value Calculation

At GoodWhale, we have conducted a comprehensive analysis of AGILENT TECHNOLOGIES’s financials. Our findings show that the intrinsic value of AGILENT TECHNOLOGIES share is around $148.7, as determined by our proprietary Valuation Line. However, AGILENT TECHNOLOGIES stock is currently trading at $128.6, which is a fair price that is undervalued by 13.5%. This presents an opportunity for investors to purchase AGILENT TECHNOLOGIES on the market at a discounted price. More…

Peers

The company has a strong presence in the market and competes with Qiagen NV, Thermo Fisher Scientific Inc, Illumina Inc, and other companies. Agilent Technologies Inc. is committed to providing innovative products and services that meet the needs of customers and enable them to achieve their research goals.

– Qiagen NV ($NYSE:QGEN)

Qiagen is a Dutch company that provides molecular diagnostic solutions, including kits and instruments for sample preparation and real-time PCR. The company has a market cap of 9.99B as of 2022 and a ROE of 13.07%.

– Thermo Fisher Scientific Inc ($NYSE:TMO)

Thermo Fisher Scientific Inc is a biotechnology company that manufactures and sells scientific instruments, reagents, and laboratory products. The company has a market capitalization of 201.37 billion as of 2022 and a return on equity of 12.43%. Thermo Fisher Scientific is a global leader in serving science, with revenues of more than $30 billion and a workforce of more than 70,000 employees. The company’s mission is to enable its customers to make the world healthier, cleaner, and safer.

– Illumina Inc ($NASDAQ:ILMN)

Illumina Inc. is an American company headquartered in San Diego, California. It is a provider of sequencing and array-based solutions for genetic analysis. The company has a market cap of $36.65 billion as of 2022 and a return on equity of 0.28%. Illumina’s products are used by academic and commercial researchers in a variety of fields, including cancer, infectious disease, genetics, and more.

Summary

The company’s Non-GAAP earnings per share (EPS) came in at $1.27, beating the consensus estimate by $0.01. Revenue of $1.72 billion was also higher than expected, surpassing expectations by $50 million. This strong performance was driven by strong sales in all segments including life sciences, diagnostics, and applied markets.

Additionally, the company showed impressive margin and cash flow characteristics which resulted in improved profitability. The strong performance of Agilent Technologies suggests the company is well positioned to generate long-term value for shareholders.